MedTrace Logo

Clinical Performance of Withings Move ECG Software for Atrial Fibrillation Detection

NCT04493749 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 234

Last updated 2026-02-18

No results posted yet for this study

Summary

Withings Move ECG watch is designed to record ECG and detect automatically atrial fibrillation. The aim of this study is to validate the performance of Move ECG watch to detect atrial fibrillation compared to a reference 12-lead ECG.

Conditions

Interventions

DIAGNOSTIC_TEST

ECG measurement

Simultaneous recording of a single-lead ECG signal with the Withings Move ECG and ECG signal for the reference 12-lead ECG

Sponsors & Collaborators

  • Withings

    lead INDUSTRY

Principal Investigators

  • Julien Nahum · Centre Cardiologique du Nord

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-20
Primary Completion
2021-03-15
Completion
2026-10-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04493749 on ClinicalTrials.gov